Nymox Pharmaceutical Balance Sheet
Nymox Pharmaceutical's total assets for Q4 2024 were $654.00K, an increase of 4.31% from the previous quarter. NYMXF total liabilities were $7.43M for the fiscal quarter, a 95.50% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.